Welcome to the Healthcare Diversity Council! Here we strongly believe in a global representation in hospitals and clinics across the country, that every healthcare institution should mirror the environment and patients that it serves.
There are many opportunities to volunteer your time and talent in creating greater diversity and inclusion in Healthcare. Our volunteers get involved in all aspects of event planning and implementation, as well as outreach, communication, and advocacy within their organization and the community…
A Renewed Outlook on Substance Use Prevention
by Elizabeth Adams, Kelli Komro, and Erin Bonar
An Opportunity to Get Ahead of the Overdose Crisis For many Americans, drug use ‘prevention’ conjures memories of early public health campaigns using fearsome imagery and catchy slogans to deter substance use. Campaigns implored youth to “just say no” to drugs, and the public received stark warnings: “this is your brain on drugs.” Prevention science… Read More » Author information Elizabeth Adams Dr. Elizabeth Troutman Adams is a health communication scientists with a special interest in societal perceptions of substance use disorder. She is passionate about delivering health science to society through messages and campaigns that are accessible, relatable, and relevant to everyone. | The post A Renewed Outlook on Substance Use Prevention appeared first on The Medical Care Blog.
Healthy Intersections Podcast: January 2023
by Lisa M. Lines
This month’s podcast features a round-up of this month’s blog posts and an interview with Sungchul Park of Drexel University about his recent Medical Care paper on Medicare Advantage Star Ratings and disparities in ambulatory care sensitive hospitalizations. Listen here or via your favorite podcast platform! Transcript (partial): Hello listeners, and welcome to the Healthy… Read More » Author information Lisa M. Lines Senior health services researcher at RTI International Lisa M. Lines, PhD, MPH is a senior health services researcher at RTI International, an independent, non-profit research institute. She is also an Assistant Professor in Population and Quantitative Health Sciences at the University of Massachusetts Chan Medical School. Her research focuses on social drivers of health, quality of care, care experiences, and health outcomes, particularly among people with chronic or serious illnesses. She is co-editor of TheMedicalCareBlog.com and serves on the Medical Care Editorial Board. She also serves as chair of the APHA Medical Care Section's Health Equity Committee. Views expressed are the author's and do not necessarily reflect those of RTI or UMass Medical School. | Twitter | LinkedIn | The post Healthy Intersections Podcast: January 2023 appeared first on The Medical Care Blog.
Is It Time for Medicaid-For-All?
by Gregory Stevens
It isn’t what supporters of single-payer health care might prefer. But a Medicaid-for-all program, based on the already expansive safety-net program, might open new doors to universal coverage. And rising familiarity with the program is creating a window of opportunity. My realization began with several conversations First, it was a friend going through a divorce… Read More » Author information Gregory Stevens Professor at California State University, Los Angeles Gregory D. Stevens, PhD, MHS is a health policy researcher, writer, teacher and advocate. He is a professor of public health at California State University, Los Angeles. He received both his masters and PhD from the Johns Hopkins University Bloomberg School of Public Health, with a focus on health care policy. He has focused his research on primary health care, children’s health, health disparities and vulnerable populations. He is a co-author of the book Vulnerable Populations in the United States. | Twitter | The post Is It Time for Medicaid-For-All? appeared first on The Medical Care Blog.
Using CLAS Standards to Advance Equity
by Sunnie Hodge and Lawren Bercaw
To address calls for improving health equity, organizations could consider using CLAS Standards to advance diversity, equity, and inclusion (DEI). In recent years, health organization leaders have prioritized the need to address systemic inequities. A 2021 survey of health care organizations identified health equity as a top priority [pdf]. This focus has grown since the… Read More » Author information Sunnie Hodge Sunnie Hodge is a public health researcher at RTI International. Her experience includes conducting interviews, surveys, focus groups, and data analyses related to health care for older adults and people with disabilities, HIV prevention, and the impact of racism on health. Her interests include LGBTQIA+ health, social determinants of health, and health equity. She has a bachelor's in public health from Simmons University. | LinkedIn | The post Using CLAS Standards to Advance Equity appeared first on The Medical Care Blog.
Reporting detention-related harms
by Ranit Mishori, Kathryn Hampton, Marsha Griffin, and Nancy E. Wang
Community-based clinicians sometimes see patients who have been recently released from immigration detention. Those encounters can be challenging, especially when patients reveal health harms experienced while in detention. It is obviously critical that clinicians provide high-quality medical care and address any health issues potentially brought about or exacerbated by their detention history. But do they… Read More » Author information Ranit Mishori Professor of Family Medicine at Georgetown University School of Medicine Ranit Mishori, MD, MHS, FAAFP is a Professor of Family Medicine at Georgetown University School of Medicine, and Senior Medical Advisor at Physicians for Human Rights. Dr. Mishori's areas of interest and expertise include public health, migrant and refugee health, health and human rights. | Twitter | LinkedIn | The post Reporting detention-related harms appeared first on The Medical Care Blog.
Innovation’s Opportunity In Healthcare
by Joe Babaian
Blog by Joe Babaian For True Innovation, Don’t Rely On Your Own Ideas. This is an exciting take from Daniel Terdiman of Fast Company. How often do we consider disruptive and incremental innovation as the lifeblood of our journey? This is what all of us are really about – making a difference, not settling for
Are Healthcare Moonshots Effective?
by Colin Hung
When President John F Kennedy committed to landing a man on the Moon by the end of the decade during his 1961 speech to Congress, he rallied the nation behind that single goal. What happened after was an explosion of innovation and investment in the space program. Kennedy’s “moonshot” has become a template for rallying
Trust in Healthcare
by Joe Babaian
Blog post by Joe Babaian Now in 2023, more than ever, we think about trust in healthcare – the system and the medical profession are rooted in experience, connections, and perception. Different segments of society have varying levels of trust based on socio-economic status, race, and level of interaction with the healthcare system, to name
What will we do differently in 2023?
by Colin Hung
It has become a HCLDR tradition to start each new calendar year with a tweetchat about our plans for the next 12 months. We used to share our resolutions, but over the past few years that has become passé. Resolutions are often too lofty and unachievable. So instead, we have shared the realistic plans and
Looking back at healthcare in 2022
by Colin Hung
Can you believe that we’ve reached the end of 2022? This year has been a truly unique one. At times this year has felt like it would never end – like when travel restrictions were still in place at the beginning of the year. At other times, I felt like I blinked and a month
WHO updates critical medicines list for radiological and nuclear emergencies
The World Health Organization (WHO) today updated its list of medicines that should be stockpiled for radiological and nuclear emergencies, along with policy advice for their appropriate management.
WHO launches funding appeal to help a record number of people in complex, intersecting health emergencies
WHO is launching its 2023 health emergency appeal today for US$ 2.54 billion to provide assistance to millions of people around the world facing health emergencies. The number of people in need of humanitarian relief has increased by almost a quarter compared to 2022, to a record 339 million.Currently, WHO is responding to an unprecedented number of intersecting health emergencies: climate change-related disasters such as flooding in Pakistan and food insecurity across the Sahel and in the greater Horn of Africa; the war in Ukraine; and the health impact of conflict in Yemen, Afghanistan, Syria and northern Ethiopia – all of these emergencies overlapping with the health system disruptions caused by the COVID-19 pandemic and outbreaks of measles, cholera, and other killers.“This unprecedented convergence of crises demands an unprecedented response,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “More people than ever before face the imminent risk of disease and starvation and need help now. The world cannot look away and hope these crises resolve themselves. I urge donors to be generous and help WHO to save lives, prevent the spread of disease within and across borders, and support communities as they rebuild."WHO is currently responding to 54 health crises around the world, 11 of which are classified as Grade 3, WHO’s highest level of emergency, requiring a response at all three levels of the organization. As it is often the case, the most vulnerable are the worst hit. In 2022, WHO provided medicines, other supplies, training for doctors and other health workers, vaccines, enhanced disease surveillance, mobile clinics, mental health support, maternal health consultations and much more. WHO delivers cost-effective, high-impact responses that protect health, lives and livelihoods. Every US$ 1 invested in WHO generates at least US$ 35 in return on investment*.WHO responds to health emergencies in close collaboration with Member States, other UN agencies, non-governmental organizations, civil society organizations and other partners in the communities and across countries and regions. The appeal will be launched at an event from WHO’s Headquarters in Geneva, hosted by WHO’s Director-General, Dr Tedros Adhanom Ghebreyesus. It will be webcast from this page, and on WHO’s YouTube channel, Twitter, LinkedIn.ResourcesWHO Global Health Appeal 2023. Read more about the work of WHO in emergencies.Related photosClick here to register for access to WHO photo library (one time registration required).Note to editors:WHO is responding to Grade 3 health emergencies in Afghanistan, the Democratic Republic of the Congo, the greater Horn of Africa, Northern Ethiopia, Somalia, South Sudan, the Syrian Arab Republic, Ukraine, and Yemen. The COVID-19 pandemic and mpox (monkeypox) outbreaks are also Grade 3 emergencies. See more about health emergencies.*A Healthy Return. Investment case for a sustainably financed WHO, May 2022.
Five billion people unprotected from trans fat leading to heart disease
Five billion people globally remain unprotected from harmful trans fat, a new status report from WHO has found, increasing their risk of heart disease and death. Since WHO first called for the global elimination of industrially produced trans fat in 2018 – with an elimination target set for 2023 – population coverage of best-practice policies has increased almost six-fold. Forty-three countries have now implemented best-practice policies for tackling trans fat in food, with 2.8 billion people protected globally. Despite substantial progress, however, this still leaves 5 billion worldwide at risk from trans fat’s devastating health impacts with the global goal for its total elimination in 2023 remaining unattainable at this time. Industrially produced trans fat (also called industrially produced trans-fatty acids) is commonly found in packaged foods, baked goods, cooking oils and spreads. Trans fat intake is responsible for up to 500 000 premature deaths from coronary heart disease each year around the world. “Trans fat has no known benefit, and huge health risks that incur huge costs for health systems,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “By contrast, eliminating trans fat is cost effective and has enormous benefits for health. Put simply, trans fat is a toxic chemical that kills, and should have no place in food. It’s time to get rid of it once and for all.” Currently, 9 of the 16 countries with the highest estimated proportion of coronary heart disease deaths caused by trans fat intake do not have a best-practice policy. They are Australia, Azerbaijan, Bhutan, Ecuador, Egypt, Iran (Islamic Republic of), Nepal, Pakistan and Republic of Korea.Best-practices in trans fat elimination policies follow specific criteria established by WHO and limit industrially produced trans fat in all settings. There are two best-practice policy alternatives: 1) mandatory national limit of 2 grams of industrially produced trans fat per 100 grams of total fat in all foods; and 2) mandatory national ban on the production or use of partially hydrogenated oils (a major source of trans fat) as an ingredient in all foods.“Progress in eliminating trans fat is at risk of stalling, and trans fat continues to kill people,” said Dr Tom Frieden, President and CEO of Resolve to Save Lives. “Every government can stop these preventable deaths by passing a best-practice policy now. The days of trans fat killing people are numbered – but governments must act to end this preventable tragedy." While most trans fat elimination policies to date have been implemented in higher-income countries (largely in the Americas and in Europe), an increasing number of middle-income countries are implementing or adopting these policies, including Argentina, Bangladesh, India, Paraguay, Philippines and Ukraine. Best-practice policies are also being considered in Mexico, Nigeria and Sri Lanka in 2023. If passed, Nigeria would be the second and most populous country in Africa to put a best-practice trans fat elimination policy in place. No low-income countries have yet adopted a best-practice policy to eliminate trans fat.In 2023, WHO recommends that countries focus on these four areas: adopting best-practice policy, monitoring and surveillance, healthy oil replacements and advocacy. WHO guidance has been developed to help countries make rapid advances in these areas. WHO also encourages food manufacturers to eliminate industrially produced trans fat from their products, aligning to the commitment made by the International Food and Beverage Alliance (IFBA). Major suppliers of oils and fats are asked to remove industrially produced trans fat from the products sold to food manufacturers globally.The report, called Countdown to 2023 WHO Report on global trans fat elimination 2022, is an annual status report published by WHO in collaboration with Resolve to Save Lives, to track progress towards the goal of trans fat elimination in 2023. For editors: The World Health Organization has partnered with Resolve to Save Lives, a not-for-profit organization, to support the development and implementation of the REPLACE action package. Launched in 2018, the WHO’s REPLACE action package provides a strategic approach to eliminating industrially produced trans fat from national food supplies. Since 2017, Bloomberg Philanthropies has supported Resolve to Save Lives’ global efforts to save lives from cardiovascular health disease. To find out more, visit: https://www.resolvetosavelives.org or Twitter @ResolveTSL
WHO urges action to protect children from contaminated medicines
WHO is releasing an urgent call to action to countries to prevent, detect and respond to incidents of substandard and falsified medical products. Over the past four months, countries have reported on several incidents of over-the-counter cough syrups for children with confirmed or suspected contamination with high levels of diethylene glycol (DEG) and ethylene glycol (EG). The cases are from at least seven countries, associated with more than 300 fatalities in three of these countries. Most are young children under the age of five. These contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even taken in small amounts, and should never be found in medicines. Based on country reports, WHO has issued three global medical alerts addressing these incidents. The Medical Product Alert N°6/2022 on 5 October 2022 focused on the outbreak in the Gambia, Medical Product Alert N°7/2022 on 6 November 2022 focused on Indonesia, and Medical Product Alert No1/2023 on 11 January 2023 focused on Uzbekistan.WHO’s medical product alerts were rapidly disseminated to the national health authorities of all 194 WHO Member States. These medical product alerts requested, inter alia: (a) the detection and removal of contaminated medicines from circulation in the markets, (b) increased surveillance and diligence within the supply chains of countries and regions likely to be affected, (c) immediate notification to WHO if these substandard products are discovered in-country; and otherwise inform the public of the dangers and toxic effects of the substandard medicines at issue. Since these are not isolated incidents WHO calls on various key stakeholders engaged in the medical supply chain to take immediate and coordinated action. WHO calls on regulators and governments to: detect and remove from circulation in their respective markets any substandard medical products that have been identified in the WHO medical alerts referred to above as potential causes of deaths and disease; ensure that all medical products in their respective markets are approved for sale by competent authorities and obtainable from authorized/licensed suppliers; assign appropriate resources to improve and increase risk-based inspections of manufacturing sites within their jurisdiction in accordance with international norms and standards;increase market surveillance including risk-based targeted testing for medical products released in their respective markets including informal markets; andenact and enforce, where relevant and as appropriate, laws and other relevant legal measures to help combat the manufacture, distribution and/or use of substandard and falsified medicines.WHO calls on manufacturers of medicines to: only purchase pharmaceutical grade excipients from qualified and bona fide suppliers;conduct comprehensive testing upon receipt of supplies and before use in manufacture of finished products;provide assurance of product quality including through certificates of analyses based on appropriate testing results; andkeep accurate, complete and proper records of purchase of materials, testing, manufacture, and distribution to facilitate traceability during investigations in case of incidents.WHO urges all suppliers and distributors of medical products to: always check for signs of falsification and physical condition of medicines and other health products they distribute and/or sell; only distribute and/or sell medicines authorized by, and from sources approved by, competent authorities;keep accurate, complete and proper records relating to the medicines and their distribution and/or sale; andengage competent personnel to handle medicines and provide advice to the public on appropriate use of the medicines.In addition, WHO will continue to work with the Member State Mechanism on substandard and falsified medical products in implementing its mandate to promote effective collaboration in the prevention, detection and response to substandard and falsified medical products to save lives.
Small Island Developing States accelerate action to tackle biggest killers
The Government of Barbados, the World Health Organization (WHO) and the Pan American Health Organization are holding a high-level technical meeting on noncommunicable diseases (NCDs) and mental health with Small Island Developing States (SIDS).